Overexpression of spondin-2 in gastric cancer was significantly associated with well differentiation (P = 0.015), depth of invasion (P < 0.001), lymph node metastasis (P = 0.001), and advanced TNM stages (P = 0.004). This evidence concerns the gene SPON2 and gastric cancer.